These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 38793589)

  • 41. Reprogrammed CRISPR-Cas13b suppresses SARS-CoV-2 replication and circumvents its mutational escape through mismatch tolerance.
    Fareh M; Zhao W; Hu W; Casan JML; Kumar A; Symons J; Zerbato JM; Fong D; Voskoboinik I; Ekert PG; Rudraraju R; Purcell DFJ; Lewin SR; Trapani JA
    Nat Commun; 2021 Jul; 12(1):4270. PubMed ID: 34257311
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Viral MicroRNAs Encoded by Nucleocapsid Gene of SARS-CoV-2 Are Detected during Infection, and Targeting Metabolic Pathways in Host Cells.
    Meng F; Siu GK; Mok BW; Sun J; Fung KSC; Lam JY; Wong NK; Gedefaw L; Luo S; Lee TMH; Yip SP; Huang CL
    Cells; 2021 Jul; 10(7):. PubMed ID: 34359932
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Vero cell-adapted SARS-CoV-2 strain shows increased viral growth through furin-mediated efficient spike cleavage.
    Minami S; Kotaki T; Sakai Y; Okamura S; Torii S; Ono C; Motooka D; Hamajima R; Nouda R; Nurdin JA; Yamasaki M; Kanai Y; Ebina H; Maeda Y; Okamoto T; Tachibana T; Matsuura Y; Kobayashi T
    Microbiol Spectr; 2024 Apr; 12(4):e0285923. PubMed ID: 38415690
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Arginine methylation of SARS-Cov-2 nucleocapsid protein regulates RNA binding, its ability to suppress stress granule formation, and viral replication.
    Cai T; Yu Z; Wang Z; Liang C; Richard S
    J Biol Chem; 2021 Jul; 297(1):100821. PubMed ID: 34029587
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Molecular Determinants of SARS-CoV-2 Variants.
    Banerjee A; Mossman K; Grandvaux N
    Trends Microbiol; 2021 Oct; 29(10):871-873. PubMed ID: 34373192
    [TBL] [Abstract][Full Text] [Related]  

  • 46. SARS-CoV-2 growth, furin-cleavage-site adaptation and neutralization using serum from acutely infected hospitalized COVID-19 patients.
    Klimstra WB; Tilston-Lunel NL; Nambulli S; Boslett J; McMillen CM; Gilliland T; Dunn MD; Sun C; Wheeler SE; Wells A; Hartman AL; McElroy AK; Reed DS; Rennick LJ; Duprex WP
    J Gen Virol; 2020 Nov; 101(11):1156-1169. PubMed ID: 32821033
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Reverse genetics of SARS-related coronavirus using vaccinia virus-based recombination.
    van den Worm SH; Eriksson KK; Zevenhoven JC; Weber F; Züst R; Kuri T; Dijkman R; Chang G; Siddell SG; Snijder EJ; Thiel V; Davidson AD
    PLoS One; 2012; 7(3):e32857. PubMed ID: 22412934
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhibition of SARS-CoV-2 coronavirus proliferation by designer antisense-circRNAs.
    Pfafenrot C; Schneider T; Müller C; Hung LH; Schreiner S; Ziebuhr J; Bindereif A
    Nucleic Acids Res; 2021 Dec; 49(21):12502-12516. PubMed ID: 34850109
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Exploration of the ocular surface infection by SARS-CoV-2 and implications for corneal donation: An ex vivo study.
    Maurin C; He Z; Mentek M; Verhoeven P; Pillet S; Bourlet T; Rogues F; Pugniet JL; Peyragrosse T; Barallon M; Perrache C; Aouimeur I; Acquart S; Ninotta S; Baud'huin M; Vabres B; Poinard S; Gain P; Thuret G
    PLoS Med; 2022 Mar; 19(3):e1003922. PubMed ID: 35231027
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The Inhaled Steroid Ciclesonide Blocks SARS-CoV-2 RNA Replication by Targeting the Viral Replication-Transcription Complex in Cultured Cells.
    Matsuyama S; Kawase M; Nao N; Shirato K; Ujike M; Kamitani W; Shimojima M; Fukushi S
    J Virol; 2020 Dec; 95(1):. PubMed ID: 33055254
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long-chain polyphosphates impair SARS-CoV-2 infection and replication.
    Ferrucci V; Kong DY; Asadzadeh F; Marrone L; Boccia A; Siciliano R; Criscuolo G; Anastasio C; Quarantelli F; Comegna M; Pisano I; Passariello M; Iacobucci I; Monica RD; Izzo B; Cerino P; Fusco G; Viscardi M; Brandi S; Pierri BM; Borriello G; Tiberio C; Atripaldi L; Bianchi M; Paolella G; Capoluongo E; Castaldo G; Chiariotti L; Monti M; De Lorenzo C; Yun KS; Pascarella S; Cheong JH; Kim HY; Zollo M
    Sci Signal; 2021 Jul; 14(690):. PubMed ID: 34230209
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A Recombinant Fragment of Human Surfactant Protein D Binds Spike Protein and Inhibits Infectivity and Replication of SARS-CoV-2 in Clinical Samples.
    Madan T; Biswas B; Varghese PM; Subedi R; Pandit H; Idicula-Thomas S; Kundu I; Rooge S; Agarwal R; Tripathi DM; Kaur S; Gupta E; Gupta SK; Kishore U
    Am J Respir Cell Mol Biol; 2021 Jul; 65(1):41-53. PubMed ID: 33784482
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Generation of Recombinant SARS-CoV-2 Using a Bacterial Artificial Chromosome.
    Chiem K; Ye C; Martinez-Sobrido L
    Curr Protoc Microbiol; 2020 Dec; 59(1):e126. PubMed ID: 33048448
    [TBL] [Abstract][Full Text] [Related]  

  • 54. siRNA targeting the leader sequence of SARS-CoV inhibits virus replication.
    Li T; Zhang Y; Fu L; Yu C; Li X; Li Y; Zhang X; Rong Z; Wang Y; Ning H; Liang R; Chen W; Babiuk LA; Chang Z
    Gene Ther; 2005 May; 12(9):751-61. PubMed ID: 15772689
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Analysis of SARS-CoV-2 infection dynamic in vivo using reporter-expressing viruses.
    Ye C; Chiem K; Park JG; Silvas JA; Morales Vasquez D; Sourimant J; Lin MJ; Greninger AL; Plemper RK; Torrelles JB; Kobie JJ; Walter MR; de la Torre JC; Martinez-Sobrido L
    Proc Natl Acad Sci U S A; 2021 Oct; 118(41):. PubMed ID: 34561300
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Quantitative proteomics analysis reveals BAG3 as a potential target to suppress severe acute respiratory syndrome coronavirus replication.
    Zhang L; Zhang ZP; Zhang XE; Lin FS; Ge F
    J Virol; 2010 Jun; 84(12):6050-9. PubMed ID: 20392858
    [TBL] [Abstract][Full Text] [Related]  

  • 57. SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory Tract.
    Hou YJ; Okuda K; Edwards CE; Martinez DR; Asakura T; Dinnon KH; Kato T; Lee RE; Yount BL; Mascenik TM; Chen G; Olivier KN; Ghio A; Tse LV; Leist SR; Gralinski LE; Schäfer A; Dang H; Gilmore R; Nakano S; Sun L; Fulcher ML; Livraghi-Butrico A; Nicely NI; Cameron M; Cameron C; Kelvin DJ; de Silva A; Margolis DM; Markmann A; Bartelt L; Zumwalt R; Martinez FJ; Salvatore SP; Borczuk A; Tata PR; Sontake V; Kimple A; Jaspers I; O'Neal WK; Randell SH; Boucher RC; Baric RS
    Cell; 2020 Jul; 182(2):429-446.e14. PubMed ID: 32526206
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A Convenient and Biosafe Replicon with Accessory Genes of SARS-CoV-2 and Its Potential Application in Antiviral Drug Discovery.
    Jin YY; Lin H; Cao L; Wu WC; Ji Y; Du L; Jiang Y; Xie Y; Tong K; Xing F; Zheng F; Shi M; Pan JA; Peng X; Guo D
    Virol Sin; 2021 Oct; 36(5):913-923. PubMed ID: 33999369
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Bacterial Artificial Chromosome Reverse Genetics Approaches for SARS-CoV-2.
    Chiem K; Nogales A; Almazán F; Ye C; Martínez-Sobrido L
    Methods Mol Biol; 2024; 2733():133-153. PubMed ID: 38064031
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.
    Busnadiego I; Fernbach S; Pohl MO; Karakus U; Huber M; Trkola A; Stertz S; Hale BG
    mBio; 2020 Sep; 11(5):. PubMed ID: 32913009
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.